MedPath

The effect of laparoscopic salpingostomy, laparotomy, and methotrexate treatment on hysterosalpingography results

Phase 2
Conditions
Ectopic pregnancy.
Ectopic pregnancy
O.00
Registration Number
IRCT20201111049352N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
99
Inclusion Criteria

Mass diameter less than 3.5cm
Stable hemodynamics
Beat human chorionic gonadotrophin (BHCG) less than 5000 mIU/mL
Satisfaction to participate in the study

Exclusion Criteria

Ectopic pregnancy recurrence
Fetal cardiac activity in ectopic pregnancy
Having liver and kidney disease
Having lung disease
Having an active stomach ulcer
Breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ectopic pregnancy mass siza. Timepoint: Three months after intervention. Method of measurement: Imaging.;Infection. Timepoint: Three months after intervention. Method of measurement: Examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath